Defense and Federal Agencies Get Boost: Golden State Medical Supply Awarded $10.3M for Duloxetine Hydrochloride Capsules

Golden State Medical Supply Inc.,* Camarillo, California, has been awarded a maximum $10,306,354 modification (P00008) exercising the fourth one-year option period of a one-year base contract (SPE2D2-20-D-0098) with four one-year option periods for duloxetine hydrochloride delayed release capsules. This is a fixed-price, requirements contract. The performance completion date is Sept. 16, 2025. Using customers are Army, Navy, Air Force, Marine Corps, Coast Guard, Department of Veterans Affairs, Indian Health Services, and Federal Bureau of Prisons. Type of appropriation is fiscal 2024 through 2025 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.